<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557852</url>
  </required_header>
  <id_info>
    <org_study_id>202006093RIND</org_study_id>
    <nct_id>NCT04557852</nct_id>
  </id_info>
  <brief_title>Mid-term Follow-up for Tailored ATVM</brief_title>
  <official_title>Clinical Outcome and Urodynamic Changes of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse: a Mid-term Follow-up With a Median Duration of 30 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower urinary tract symptoms may change after pelvic organ prolapse surgery. Thus, the aim of&#xD;
      this study was to elucidate (1) the changes of lower urinary tract symptoms and (2) the&#xD;
      changes in values of urodynamic parameters between baseline and after pelvic organ prolapse&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between November 2011 and December 2015, medical records of all consecutive women who&#xD;
      underwent anterior transvaginal mesh surgery (ATVM) but without concomitant mid-urethral&#xD;
      sling surgery were reviewed. Data of pre- and post-operative lower urinary tract symptoms and&#xD;
      urodynamic parameters were compared. The bladder outlet obstruction was defined when the&#xD;
      detrusor pressure at maximum flow rate was not less than 40cmH2O, and the maximum flow rate&#xD;
      was less than 12 mL/s. Overactive bladder syndrome, detrusor overactivity, bladder&#xD;
      oversensitivity and urodynamic stress incontinence were also recognized as international&#xD;
      continence society definition. STATA software was used for statistical analysis. Wilcoxon&#xD;
      signed-rank test or McNemar's test was used for statistical analysis as appropriate. P &lt; 0.05&#xD;
      was considered as statistically significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2011</start_date>
  <completion_date type="Actual">December 31, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Voiding difficulty</measure>
    <time_frame>November 2011 to December 2015</time_frame>
    <description>Weak stream of urination, intermittency, strain to void or incomplete empty sensation after the anterior transvaginal mesh surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overactive bladder syndrome</measure>
    <time_frame>November 2011 to December 2015</time_frame>
    <description>Urinary urgency, with or without incontinence, may accompany with urinary frequency and nocturia.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">160</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <arm_group>
    <arm_group_label>Anterior transvaginal mesh group</arm_group_label>
    <description>Women received anterior transvaginal mesh surgery without concomitant mid-urethral sling surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ATVM</intervention_name>
    <description>Tailored anterior transvaginal mesh for pelvic organ prolapse</description>
    <arm_group_label>Anterior transvaginal mesh group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Between November 2011 and December 2015, medical records of all consecutive women who&#xD;
        underwent anterior transvaginal mesh surgery for their advanced pelvic organ prolapse were&#xD;
        reviewed.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with pelvic organ prolapse&#xD;
&#xD;
          -  Women received anterior transvaginal mesh surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant mid-urethral sling surgery&#xD;
&#xD;
          -  Chronic urinary tract infection&#xD;
&#xD;
          -  Interstitial cystitis&#xD;
&#xD;
          -  Malignancy history in pelvic organ&#xD;
&#xD;
          -  Ever received pelvic radiation&#xD;
&#xD;
          -  Concomitant transabdominal surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ho-Hsiung Lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN; International Urogynecological Association; International Continence Society. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798. Review.</citation>
    <PMID>19941278</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu PC, Wu CH, Lin KL, Liu Y, Loo Z, Lee YC, Long CY. Predictors for de novo stress urinary incontinence following pelvic reconstruction surgery with transvaginal single-incisional mesh. Sci Rep. 2019 Dec 16;9(1):19166. doi: 10.1038/s41598-019-55512-0.</citation>
    <PMID>31844157</PMID>
  </results_reference>
  <results_reference>
    <citation>Long CY, Wang CL, Lin KL, Ker CR, Loo Z, Liu Y, Wu PC. Laparoscopic Long Mesh Surgery with Augmented Round Ligaments: A Novel Uterine Preservation Procedure For Apical Pelvic Organ Prolapse. Sci Rep. 2020 Apr 20;10(1):6615. doi: 10.1038/s41598-020-63725-x.</citation>
    <PMID>32313187</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang TC, Hsiao SM, Chen CH, Wu WY, Lin HH. Clinical Outcomes and Urodynamic Effects of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse. Biomed Res Int. 2015;2015:191258. doi: 10.1155/2015/191258. Epub 2015 Nov 8.</citation>
    <PMID>26634203</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang TC, Hsiao SM, Wu PC, Chen CH, Wu WY, Lin HH. Comparison of clinical outcomes between tailored transvaginal mesh surgery and native tissue repair for pelvic organ prolapse. J Formos Med Assoc. 2019 Dec;118(12):1623-1632. doi: 10.1016/j.jfma.2019.08.034. Epub 2019 Sep 18.</citation>
    <PMID>31542332</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pelvic organ prolapse</keyword>
  <keyword>Transvaginal mesh</keyword>
  <keyword>lower urinary tract symptoms</keyword>
  <keyword>Urodynamic study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will be shared under reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

